Cancer treatment has seen significant advancements in recent years with the introduction of innovative therapies. AstraZeneca’s Imfinzi (durvalumab) has emerged as a key contributor in this evolution.

MG is a brand that’s rapidly on the up. Between 2021 and 2023, it has seen a hefty 64 per cent growth in its sales, lifting the brand from 18,000 sales in 2020 to 81,000 last year. Cars like ...

MG is a brand that’s rapidly on the up. Between 2021 and 2023, it has seen a hefty 64 per cent growth in its sales, lifting the brand from 18,000 sales in 2020 to 81,000 last year. Cars like ...

The best TVs under $500 are a lot better than you'd expect them to be. Years ago, spending $500 on a new TV might only get you 1080p resolution and a 40-inch screen. These days, it's definitely ...

Both Tagrisso and Imfinzi have been recommended by England’s NICE to treat patients with lung cancer in England and Wales. Credit: Roland Magnusson via Getty Images. · Pharmaceutical Technology ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

Although MG hasn’t revealed exact specifications yet, going by the dimensions of the international-spec D90 Max, the Majestor could measure 5,046mm in length, 2,016mm in width and 1,876mm in ...

AstraZeneca (AZ) has received two separate recommendations from the National Institute for Health and Care Excellence (NICE) for use of its lung cancer drugs Tagrisso (osimertinib) and Imfinzi ...

Both Tagrisso and Imfinzi have been recommended by England’s NICE to treat patients with lung cancer in England and Wales. Credit: Roland Magnusson via Getty Images. AstraZeneca has received two ...

Rugby league personality Mark ‘MG’ Geyer is joining Sydney’s 2GB and Nine Radio on a three-year deal. The NSW and Australian representative and NRL premiership winner will be heard daily on 2GB’s new ...

NRL legend Mark ‘MG’ Geyer, who was let go from Triple M after 17 years on air, has landed a new high profile radio gig. Geyer has signed a three year deal with 2GB radio in Sydney ...

The treatment was approved in 2024 for chronic graft-vs-host disease after failure of at least 2 prior lines of systemic therapy in patients weighing at least 40kg. The Food and Drug ...